Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 7,403 shares at $24.46 ($176K) on 2023-09-26, disclosed to the SEC on 2023-09-27.
Open-market sale of $176k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.54 | 1,883 | $42K | 24.1% |
| 2 | $23.51 | 1,114 | $26K | 14.8% |
| 3 | $24.46 | 2,203 | $54K | 30.5% |
| 4 | $24.46 | 2,203 | $54K | 30.5% |
| Total | $23.83 avg | 7,403 | $176K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |